A Markov model for estimating the cost-effectiveness of immunotherapy for newly diagnosed multiple myeloma patients. - Massimo Bilancia; Antonio Giovanni Solimando; Fabio Manca; Angelo Vacca; Roberto Ria (Comput. Stat. Data Anal., 2025)